Boeing Distinguished Professor of Pharmaceutical Sciences Philip Lazarus, Pharmaceutical Sciences Associate in Research Christy Watson and two other co-authors published, “Cannabinoid metabolites as inhibitors of major hepatic CYP450 enzymes, with implications for cannabis-drug interactions” in Drug Metabolism and Disposition in September 2021.
Philip Lazarus, Christy Watson, Pharmaceutical Sciences Associate Professor Gang Chen and three other co-authors published, “Inhibition of UDP-glucuronosyltransferase enzymes by major cannabinoids and their metabolites,” in Drug Metabolism and Disposition in September 2021.
Allen I. White Distinguished Associate Professor of Pharmacotherapy Joshua Neumiller and four co-authors published, “Optimizing use of SGLT2 inhibitors and other evidence-based therapies to improve outcomes in patients with type 2 diabetes and chronic kidney disease: An opportunity for pharmacists,” in the American Journal of Health-System Pharmacy in June 2021.
Josh Neumiller and two co-authors published, “Easing the financial burden of diabetes management: a guide for patients and primary care clinicians,” in the Practical Pointers section of Clinical Diabetes, a publication by the American Diabetes Association, in August 2021.
J. Roberts and Marcia Fosberg Distinguished Regents Professor of Pharmacotherapy and Director of the Drug Information Center Danial Baker published, “Dasiglucagon,” in Hospital Pharmacy in September 2021.
Danial Baker published, “Drug evaluation – ibrexafungerp (Brexafemme),” in Wolters Kluwer Health’s The Formulary Monograph Service (FMS) in September 2021. Wolters Kluwer Health is a drug and health information publisher, the FMS is a resource used in the formulary decision making process for hospitals and managed care systems on recently released and investigational drugs.
Pharmacotherapy Clinical Professor and Director of Quality Assurance Improvement & Accreditation Preparation Terri Levien and Danial Baker published, “Drug evaluation – aducanumab (Aduhelm),” in the FMS in September 2021.
Terri Levien and Danial Baker published, “Drug evaluation – olanzapine/samidorphan (Lybalvi),” in the FMS in September 2021.
Danial Baker published, “Drug utilization evaluation – torsemide (Soaanz),” in the FMS in September 2021.
Pharmacotherapy Associate Professor Megan Undeberg and co-presenters participated in the AACP annual meeting presentation, “Strike up the band: 200 years of pharmacy education.”
Josh Neumiller presented “Meeting people with diabetes where they are: lessons learned from the home environment,” for the Maryland Chapter of the Association for Diabetes Care & Education Specialists (ADCES) on September 21, 2021.
Range Community Clinic Ambulatory Care Fellow Alexander Maciejewski served as a panelist in the Pharmacy Times webcast discussion, “Culturally appropriate care in the pharmacy: treating underserved or marginalized patient populations,” on September 13, 2021.
Pharmacotherapy Associate Professor and Director for the Center for Pharmacy Practice Research Kimberly McKeirnan, Pharmacotherapy Associate Professor and Associate Dean for External Relations Julie Akers, and one co-author published, “Pharmacy technicians are valued more than ever: insights into a team-centered immunization approach,” in the Influenza Guide for Pharmacists supplement in Pharmacy Times in July 2021.
United States Transuranium and Uranium Registries (USTUR) Assistant Professor Maia Avtandilashvili was appointed as a member of the National Council on Radiation Protection (NCRP) Scientific Committee 6-13, “Methods and models for estimating organ doses from intakes of radium.”
USTUR Director and Professor Sergei Tolmachev will serve as a subject matter expert in the area of measurements for NCRP Scientific Committee 6-13, “Methods and models for estimating organ doses from intakes of radium.”
Pharmaceutical Sciences Associate Professor Sue Marsh served as a panelist for the American College of Sports Medicine’s webinar discussion about the film, “Picture a Scientist,” on September 22, 2021.
Pharmaceutical Sciences Professor and Interim Chair Kathryn “Kay” Meier was selected as a 2021 Fellow of the American Society for Pharmacology and Experimental Therapeutics (ASPET).
Grants and Awards
Pharmaceutical Sciences Associate Professor and Director of Industry Engagement Bhagwat Prasad received $2,995,048 from Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), NIH for a five-year research project titled, “Ontogeny of drug transport.”
Pharmaceutical Sciences and Molecular Medicine students
Shamema Nasrin (Lazarus lab) and Yadira Pérez Páramo (PhD in Pharmaceutical Sciences, 2021) with faculty co-authors Christy Watson and Philip Lazarus published, “Cannabinoid metabolites as inhibitors of major hepatic CYP450 enzymes, with implications for cannabis-drug interactions,” in Drug Metabolism and Disposition in September 2021.
Shamema Nasrin, Keti Bardhi (Lazarus lab) and Gabriela Fort (2018 Summer Undergraduate Research Fellow) with faculty co-authors Christy Watson, Gang Chen and Philip Lazarus published, “Inhibition of UDP-glucuronosyltransferase enzymes by major cannabinoids and their metabolites,” in Drug Metabolism and Disposition in September 2021.
Shamema Nasrin presented, “Implications for cannabis-drug interactions: the inhibitory potential of major cannabinoids on UGT enzymes,” at the 24th North American ISSX virtual meeting as one of the top five predoctoral finalists.
Doctor of Pharmacy (PharmD) students
The WSU Spokane chapter of Student National Pharmaceutical Association (SNPhA) received the following awards at the NPhA/SNPhA 2021 Virtual Convention in July 2021:
- Chauncey I. Cooper Excellence Award – Large Chapter of the Year
- Four National Initiative of the Year Awards
- Operation Immunization
- Remember the Ribbon
- Fighting Diabetes
- Legislative and Membership Benefits Initiative